PREMIER BIOTECH COVID-19 IGG/IGM RAPID TEST COVID-19 Control

• Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests; this test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
• Assure COVID-19 IgG/IgM Control is intended to be used as external quality control material for the Assure COVID-19 IgG/IgM Rapid Test Device; the control can be used to verify proper performance of COVID-19 IgG/IgM Rapid Test kit
• The Assure COVID-19 IgG/IgM Rapid Test Device is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection - at this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity